Not recruiting
Arteriosclerosis+2
Not recruitingInvestigationalNo placebo
Long-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy
InvestigationalNo placebo
- Disease:ArteriosclerosisPseudoxanthoma elasticum+1
- Substances:Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Countries:
France
France- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
- Sponsor:Inozyme Pharma Inc.
